Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yujiro Ito

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Urologic Oncology|November 10, 2016
Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with first-line and subsequent second-line targeted therapy: A proposal of the modified-IMDC risk modelNobuyuki Tanaka, Ryuichi Mizuno, Yota Yasumizu, et al.
Japanese Journal of Clinical Oncology|November 9, 2018
Impact of inflammatory marker levels one month after the first-line targeted therapy initiation on progression-free survival prediction in patients with metastatic clear cell renal cell carcinomaKeiichi Ito, Ayako Masunaga, Nobuyuki Tanaka, et al.
Urologic Oncology|April 5, 2016
Effect of reclassification of the IMDC model in patients with metastatic renal cell carcinoma treated with targeted therapy in the first-line and second-line settingsNobuyuki Tanaka, Ryuichi Mizuno, Suguru Shirotake, et al.
The American Journal of Surgical Pathology|May 21, 2019
In Organ-confined Prostate Cancer, Tumor Quantitation Not Found to Aid in Prediction of Biochemical RecurrenceYujiro Ito, Emily A Vertosick, Daniel D Sjoberg, et al.
The Journal of Urology|October 10, 2018
Clinical Usefulness of Prostate and Tumor Volume Related Parameters following Radical Prostatectomy for Localized Prostate CancerYujiro Ito, Kazuma Udo, Emily A Vertosick, et al.
European Urology|December 11, 2012
The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional studyNobuyuki Tanaka, Eiji Kikuchi, Suguru Shirotake, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 14, 2019
Extensive disease among potential candidates for hemi-ablative focal therapy for prostate cancerToshikazu Takeda, Amy L Tin, Renato B Corradi, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Urologic Oncology|November 10, 2016
Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with first-line and subsequent second-line targeted therapy: A proposal of the modified-IMDC risk modelNobuyuki Tanaka, Ryuichi Mizuno, Yota Yasumizu, et al.
Japanese Journal of Clinical Oncology|November 9, 2018
Impact of inflammatory marker levels one month after the first-line targeted therapy initiation on progression-free survival prediction in patients with metastatic clear cell renal cell carcinomaKeiichi Ito, Ayako Masunaga, Nobuyuki Tanaka, et al.
Urologic Oncology|April 5, 2016
Effect of reclassification of the IMDC model in patients with metastatic renal cell carcinoma treated with targeted therapy in the first-line and second-line settingsNobuyuki Tanaka, Ryuichi Mizuno, Suguru Shirotake, et al.
The American Journal of Surgical Pathology|May 21, 2019
In Organ-confined Prostate Cancer, Tumor Quantitation Not Found to Aid in Prediction of Biochemical RecurrenceYujiro Ito, Emily A Vertosick, Daniel D Sjoberg, et al.
The Journal of Urology|October 10, 2018
Clinical Usefulness of Prostate and Tumor Volume Related Parameters following Radical Prostatectomy for Localized Prostate CancerYujiro Ito, Kazuma Udo, Emily A Vertosick, et al.
European Urology|December 11, 2012
The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional studyNobuyuki Tanaka, Eiji Kikuchi, Suguru Shirotake, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 14, 2019
Extensive disease among potential candidates for hemi-ablative focal therapy for prostate cancerToshikazu Takeda, Amy L Tin, Renato B Corradi, et al.
Pageof 8